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David Macleode, Victor H. Hua, and Matthew J. Burton a
aInternational Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK; bDepartment of Ophthalmology, Mbarara
University of Science and Technology, Mbarara, Uganda; cDepartment of Ophthalmology, University of Nairobi, Nairobi, Kenya; dDepartment
of Ophthalmology, Uganda Virus Research Institute, Entebbe, Uganda; eTropical Epidemiology Group, London School of Hygiene & Tropical
Medicine, London, UK
ABSTRACT
Purpose: To describe the care seeking journey and causes of delay among patients with Microbial
Keratitis in Uganda.
Methods: A prospective cohort of patients presenting with microbial keratitis at the two main eye
units in Southern Uganda (2016–2018). We collected information on demographics, home
address, clinical history, and presentation pathway including, order of facilities where patients
went to seek care, treatment advice, cost of care, and use of Traditional Eye Medicine.
Presentation time was noted. We compared “direct” presenters versus “indirect” presenters and
analysed predictors of delay.
Results: About 313 patients were enrolled. All were self-referred. Only 19% of the patients
presented directly to the eye hospital. Majority (52%) visited one facility before presenting, 19%
visited two facilities, 9% visited three facilities, and 2% visited four facilities. The cost of care
increased with increase in the number of facilities visited. People in a large household, further
distance from the eye hospital and those who used Traditional Eye Medicine were less likely to
come directly to the eye hospital. Visiting another facility prior to the eye hospital and use of
Traditional Eye Medicine aOR 1.58 (95%CI 1.03–2.43), p = .038 were associated with delayed
presentation to the eye hospital.
Conclusion: This study provided information on patient journeys to seek care. Delay was largely
attributable to having visited another health facility: a referral mechanism for microbial keratitis
was non-existent. There is need to explore how these health system gaps can be strengthened.
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Microbial keratitis (MK) can be caused by a range of
pathogens, including bacteria, viruses, protozoa (e.g.
acanthamoeba), and fungi (yeasts, moulds, andmicrospor-
idia). It is characterised by an acute or sub-acute onset of
pain, conjunctival hyperaemia, and corneal ulceration with
a stromal inflammatory cell infiltrate. MK frequently leads
to sight-loss fromdense corneal scarring, or even loss of the
eye, especially when the infection is severe and/or appro-
priate treatment is delayed.1 MK is important because it is
a leading causes of uniocular blindness worldwide.2,3
In Sub Saharan Africa, the incidence of MK has been
suggested to be around 180/100,000/year.4 Bacterial
(staphylococcus, streptococcus and pseudomonas) and
fungal (fusarium and aspergillus) are the most common
with an almost 50:50 proportion.5–11
In Low and Middle-Income Countries (LMIC), MK
management is often more challenging because of late
presentation, use of Traditional Eye Medicine (TEM),
insufficient diagnostic support, lack of effective drugs
and keratoplasty services.11,12
A critical step in effectively managing MK is ensuring
that patients start appropriate treatment as early as pos-
sible. This is because once the infection is well established,
there is little that can be done to change its course.13 It is
believed that many MK start following corneal abrasions.
Studies in Burma and Bhutan showed that if people with
a simple corneal abrasion applied antibacterial or anti-
fungal medication within the first 24–48 hours, there was
full recovery without any infectious sequalae.14,15
Delayed presentation of patients is a key determinant of
outcomes.12 Patients typically present at least two weeks
after the onset of the first symptoms.12 There are a number
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of factors that could contribute to this delay such as: dis-
tance from the hospital, transportation costs, poverty, self-
medication, and tortuous referral pathways through the
health system.16–18 Prior visit to a non-specialist health
facility has been implicated as a cause of delay in other
eye conditions.17,19
In Uganda, the public health system has six levels,
with the lowest point of care being at the village level
(Village Health Committee).20 However, physically,
a Health Centre II (HC II) is the lowest unit and is
located at a parish level, HC III at sub-county level, HC
IV at county level, district hospital (HC V), and referral
hospital (HC VI). These units have quite different staff-
ing and capacity in terms of service provision. There
are several different levels of private health care provi-
ders as well. Patients are referred up this tier system
depending on the complexity of their condition.
Therefore, to investigate the role of the health system
in providing care and onward referral of people with
MK, here we describe the presentation pathway and
factors associated with delayed presentation, among
patients with microbial keratitis in Uganda.
Methods
Ethical statement
This study followed the tenets of the Declaration of
Helsinki. It was approved by the London School of
Hygiene & Tropical Medicine Ethics Committee (Ref
10647), Mbarara University Research Ethics Committee
(Ref 10/04–16) and Uganda National Council for Science
and Technology (Ref HS-2303). Written informed consent
in “Runyankore” the local language was obtained before
enrolment. If the participant was unable to read, the infor-
mation was read to them by the research assistant. The
participant was then asked to place a thumbprint on the
consent form which was independently witnessed.
Study design and setting
This was part of a study where we prospectively enrolled
patients with MK that presented to Ruharo Eye Centre
(REC) and Mbarara University and Referral Hospital Eye
Centre (MURHEC) from December 2016 to March 2018.
MURHEC is a government owned tertiary eye unit estab-
lished in 2013. It provides mostly free services and sees
about 6,000–10,000 patients/year. REC is a church-based,
fee-paying tertiary eye hospital founded in the 1960s. It sees
about 20,000–25,000 patients/year. Both hospitals are in
Mbarara Municipality, South-Western Region, Uganda,
approximately 4 hours’ drive from Kampala. The two
units are about 5 km apart and work closely together.
Participants
All patients that were enrolled into the cohort study
were included. In that cohort study, we aimed to recruit
all MK cases presenting during a year in order to have
a powerful sample set to answer detailed questions
around the seasonal microbiological patterns. It was
important to recruit for a full year as MK had been
shown in other parts of the world to have seasonal
variations in its’ epidemiology.21
Study participants
The inclusion criteria for the bigger prospective study was
the presence of acute MK at presentation to the hospital
defined as EITHER (i) corneal epithelial ulceration
(≥1 mm diameter) AND corneal stromal infiltrate AND
evidence of acute ocular inflammation (e.g. Conjunctival
injection/anterior chamber inflammatory cells/hypop-
yon); OR (ii) a corneal abscess (≥1 mm diameter) AND
evidence of acute ocular inflammation. We excluded
those not willing to participate, those not willing to return
for follow-up, pregnant women, lactating mothers, those
aged below 18 years.
Data collection procedures
Patients presenting with MK were introduced to the
study and the informed consent processes followed.
They were assigned a unique study number and their
age, sex, occupation, and place of residence recorded.
A history was taken of the circumstances in which their
eye became infected, the predisposing factors (such as
trauma and use of Traditional Eye Medicine [TEM]).
A meticulous “journey” history was taken to document
the date when they developed symptoms, where and
when they sought treatment (name and level of the
health centre), what medical advice and treatment was
given (including whether they were referred to the eye
hospital or not), how much each step cost them in
Uganda shillings (transportation, consultation fees,
medicines). The total amount of money recorded was
for all the costs incurred before patients were enrolled
into the study.
The place where they first received any form of
treatment was denoted as “Facility 1”, the second
place visited (either as a result of formal referral or self-
initiated referral) was denoted “Facility 2” and so on.
GPS coordinates were generated for the patients’
addresses (to the nearest village, parish, county school,
or health centre depending on what was available on
Google maps). Presenting Log MAR (Logarithm of
Minimum Angle of Resolution) visual acuity at 2 m
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in a dark room was measured using Peek Acuity
software.22 For visual acuities of counting fingers or
less, Log MAR values were attributed as follows: count-
ing fingers, 2.0; hand movements, 2.5; perception of
light, 3.0; and no perception of light, 4.0.23 The patients
were then examined on a slit lamp and clinical signs
carefully recorded. Infiltrate size was measured as the
greatest diameter of the infiltrate (dimension 1) and
the diameter of an imaginary line perpendicular to the
widest axis (dimension 2). The final infiltrate size was
then derived as the geometrical mean of the two
diameters.24 The same was repeated after fluorescein
staining of the ulcer to measure the epithelial defect
sizes. Corneal specimens were obtained for microbio-
logical testing at Mbarara University Microbiology
Department. Patients were treated as per the hospital
treatment protocol and followed up periodically for up
to 3 months to determine their outcome.
Analysis
Data were analysed in STATA v14. “direct” presenters
were defined as participants whose first point of care
was the eye hospital (MURHEC or REC). “Indirect”
presenters are those who first went to other health
centres before presenting to the eye hospital.
Summary frequency tables of demographics and clinical
presentation of “direct” versus “indirect” presenters
were generated with appropriate statistical tests for
each variable (Wilcoxon rank sum for the continuous
variables and χ2 test for the categorical variables). To
determine where the participants came from, Google
maps was used to pinpoint to the addresses of the
participants. The presentation journey was described
using interval times in days from home to Facility 1
or from Facility 1 to Facility 2 and so on (presented as
median time in days with Inter Quartile Ranges
[IQRs]). To describe the cost of care, the total patient
expenditure at different facilities were summarised and
cumulative expenditure derived depending on how
many facilities an individual visited. Costs are pre-
sented as median expenditure in Uganda shillings
with IQRs.
Presentation time was defined as the time in days it
took a patient to come to the eye hospital after onset of
symptoms. For analysis of delay, presentation time was
divided into quartiles as “early” (0–7 days), “intermedi-
ate” (8–14 days), “late “(15–30 days), and “very late”
(>30 days). Ordinal logistic regression was performed
to determine the factors associated with these four
quartiles of “delay”, while logistic regression was per-
formed to determine factors associated with direct pre-
sentation. Univariable regression was performed to
generate crude Odds Ratios (OR). After assessing for
collinearity, variables with a p value less than 0.1 were
introduced in the multivariable model. A backward
stepwise approach was then used, until only the vari-
ables with a p value <0.05 were retained. Adjusted OR
were reported for the final model.
Results
Demographic features
During the study period, 313 patients were enrolled
into this study. The baseline characteristics of direct
versus direct presenters are shown in Table 1. Overall,
Table 1. Baseline characteristics of direct versus indirect presenters (n = 313).
Direct presenters (n = 58) Indirect presenters (n = 255)
Variable Median (IQR) (Total range) Median (IQR) (Total range) p value
Age 47 (35–60) (18–96) 47 (35–60) (18–87) 0.772
Distance to eye units 58 (16–85) (0.2–244) 87 (57–131) (2–378) 0.0001
Household population 5 (3–7) (1–14) 7 (4–8) (1–28) 0.006
Distance to nearest health centre in km* 2 (1–3) (0–14) 3 (1–4) (0–45) 0.174
Variable Category Count (%) Count (%) p value
Gender Female 22 (38%) 117 (46%) 0.271
Male 36 (62%) 138 (54%)
Occupation Farmer 34 (59%) 186 (73%) 0.031
Nonfarmer 24 (41%) 69 (27%)
Marital status Unmarried Ɨ 18 (31%) 77 (30%) 0.900
Married 40 (69%) 178 (70%)
Education status None 15 (26%) 69 (27%) 0.407
Primary 29 (50%) 133 (52%)
Secondary 7 (12%) 38 (15%)
Tertiary 7 (12%) 15 (6%)
Being head of household Yes 42 (72%) 170 (67%) 0.398
No 16 (28%) 85 (33%)
Needed an escort to hospital* Yes 24 (41%) 49 (20) <0.0001
No 34 (59%) 202 (80)
*Variables with some missing data: distance to nearest health centre was measured in km (n = 312, [direct 57]) needed an escort (n = 309, [direct 58]). Ɨ Unmarried
included single, divorced, and widowed,
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the direct and indirect presenters were similar for many
variables. However, the direct presenters lived closer to
the eye hospital (median 58 km vs. 87 km; p = .0001),
had fewer household members (median 5 people vs. 7
people; p = .006) and fewer were farmers (59% vs. 73%,
p = .031).
Table 2 shows some select clinical history and signs of
direct versus indirect presenters. Compared to indirect
presenters, direct presenters had a shorter presentation
time (median 8 days vs. 17 days; p < .0001), had slightly
better presenting vision (median Log MAR 0.65 vs. 1.3;
p = .075), a smaller infiltrate size (median 4.2 mm vs.
5.5 mm; p = .025) and a smaller epithelial defect (median
3.5 mm vs. 4.1 mm; p = .048). The proportion of people
who had used TEM was higher among the indirect (63%)
versus direct presenters (46%), p = .020. The direct and
indirect presenters had similar proportions with a history
of trauma, hypopyon, an opaque stromal opacity and
perforation.
Factors associated with direct presentation
On univariable and multivariable analysis summarised
in Table 3. People who lived far from the eye hospital
(overall p = .003), those from large households OR 0.53
(95%CI 0.32–0.85), p = .0080 and those who had used
TEM OR 0.48 (95% CI 0.25–0.90), p = .020 were less
likely to be direct presenters.
Table 2. Clinical history and clinical signs of direct versus indirect presenters (n = 313).
Direct presenters (n = 58) Indirect presenters (n = 255)
Variable Median (IQR) (Total range) Median (IQR) (Total range) p value
Presentation time in days* 8 (2–18) (0–116) 17 (8–32) (0–370) <0.0001
Presenting vision (Log MAR) 0.65 (0.1–2.5) (0–4) 1.3 (0.3–2.5) (0–4) 0.072
Infiltrate size in mm Ɨ 4.2 (2.5–7.1) (0.9–11) 5.5 (3.5–8) (0.5–13) 0.025
Epithelial defect size in mm Ɨ 3.5 (1.8–5.8) (0–11) 4.1 (2.5–6.9) (0–13) 0.048
Variable Category Count (%) Count (%) p value
History of trauma (overall 29%) ǂ Yes 14 (25%) 77 (30) 0.388
No 43 (75) 177 (70)
Used traditional eye medicine (overall 61%) Yes 27 (46) 161 (63) 0.020
No 31 (53) 94 (37)
Pain being the main complaint Yes 26 (45%) 112 44 0.121
No 32 55 143 56
Opaque stromal opacity ǂ Yes 25 (43) 107 (44) 0.918
No 33 (57) 137 (56)
Hypopyon ǂ Yes 13 (22) 81 (32) 0.151
No 45 (78) 172 (68)
Perforated at admission Yes 10 (17) 66 (26) 0.166
No 48 (83) 189 (74)
*Presentation time was measured as duration in days it took to come to the eye hospital after onset of symptoms. Ɨ geometrical of the largest diameter and
the diameter perpendicular to the largest diameter. ǂ variables that had less than 313 observations due to missing data (trauma n = 311 [direct57], opaque
stromal opacity n = 302 [direct 58], hypopyon n = 311 [direct 58]).
Table 3. Univariable and multivariable logistic regression analysis of factors associated with direct presentation to the eye hospital
(n = 309).
Variable
Univariable analysis Multivariable analysis
cOR (95% CI) p value aOR (95% CI) p value
Age in years 1.004 (0.987–1.022) 0.576
Sex (being male) 1.38 (0.77–2.48) 0.273
Marital status (being married) 0.96 (0.52–1.78) 0.900
Occupation (being a farmer) 0.52 (0.29–0.94) 0.033
Being head of household 1.31 (0.69–2.46) 0.399
Number of people in household (increase/one person) 0.59 (0.38–0.90) 0.015 0.53 (0.32–0.85) 0.008
Distance to the eye hospital
0–50 km 1 0.001 0.003
50–100 km 0.52 (0.26–1.01) 0.62 (0.30–1.27)
100–150 km 0.16 (0.05–0.44) 0.16 (0.06–0.48)
>150 km 0.42 (0.17–1.03) 0.52 (0.19–1.34)
Distance from nearest health centre (increase per 1 km) 0.92 (0.822–1.029) 0.146
Positive history of trauma 0.74 (0.38–1.44) 0.389






*patients with missing data were dropped from the model. OR less than 1 means they were less likely to come directly to the eye hospital
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Care seeking pathway
Figure 1 shows where the patients came from in rela-
tion to the eye hospital (MURHEC or REC). Most came
from the South Western region of Uganda and
a handful from Northern Tanzania. Figure 2 shows
the place where patients were first treated. Majority
(46%) sought treatment at a nearby clinic/pharmacy/
drug shop, 19% presented directly to the eye hospital,
15% were initially treated at home (either used TEM or
an old eye drop) and 17% were treated at various levels
of the health system (HC II, HC III, HC IV, and district
hospital). Some patients (2%) did not know the type of
facility where they first sought care and only 1% went
to a traditional healer’s shrine for treatment.
Figure 3 illustrates the pathway patients took to come
to the eye hospital and the different times spent on each
stage. Only 55 (20%) patients presented directly to the eye
hospital, majority (134, 51%) visited one facility before
presenting to the eye hospital, another 43 (19%) visited
two facilities, 24 (9%) visited three facilities, and 5 (2%)
visited four facilities. On average, patients took about
a week to move from one facility to the next. The shortest
response time was from onset of symptoms to Facility 1
and was even shorter among indirect presenters, median
2 days (IQR 0–5) versus direct presenters, median 8 (IQR
2–18), p < .0001. The longest interval time was from
Facility 4 to the eye hospital, median 13 (IQR 10–33).
The choice of the first facility did not affect overall pre-
sentation time. All the patients were self-referred.
Figure 1. A map of Uganda showing patients homes.
Each point represents a patient. The red circle is the eye hospital where these patients presented.
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We found in our study that most patients used TEM
after having been to a health facility (secondary use).
Out of the 188 who used TEM, only 51 used TEM as
primary treatment (47 at home and 4 at the traditional
healers’ shrine). The rest (137/188) had secondary
TEM application.
Cost of care
The cost of care in Uganda shillings (UGX) is presented in
Table 4. The cost of care increased with increase in the
number of facilities visited. There was evidence (Cuzick test
for trend p < .0001), of an association between expenditure
and number of facilities visited prior to presentation. The
lowest spend was for direct presenters where the median
expenditure was UGX 30,000 (IQR 7,000–63,000, total
range 0–385,000) and the largest spend was among patients
who had visited 4 facilities before presentation with
a median expenditure of UGX 284,000 (IQR 118,000–-
439,500, total range 96,000–864,000). Across the different
expenditure lines, medicines were the most expensive fol-
lowed by transportation, consultation fees were the least
expensive.
Factors associated with delay
We tested for associations with delay in presenting to the
eye hospital (Table 5). After adjusting for distance, visit-
ing another facility prior to the eye hospital was strongly
associated with delay but no obvious trend. Previous use
of TEM was also found to be associated with delay OR
1.58 (IQR 1.03–2.43), p = .038
Discussion
This study aimed to describe the presentation journey and
factors associated with delay. Factors associated with delay
were having visited another health facility and prior use of
Traditional Eye Medicine (TEM). This supported our
hypothesis that an initial visit to a health facility introduced
delay as had been reported previously for other eye
conditions.17,19,25 After onset of symptoms, the majority
of patients quickly visited a health facility to seek treatment.
This was an impressive median response time (within
48 hours). Although we did not explicitly ask their reasons
for presenting early to these facilities, the painful nature of
MK, proximity of the facilities and trauma (for those who
had it) could have played a role. Perhaps, if appropriate
treatment had been given or rapid referral made at this
stage, the outcomes might have been better.13,14
At the first point of contact with the health system,
there were three missed opportunities that we identified
in our study, these were: to promptly initiate appropriate
treatment; to triage and urgently refer; and health educa-
tion advice against TEM use. We discuss these below.
Firstly, the health facility where most patients presented
first were usually a nearby pharmacy/clinic. These are
mostly private clinics that have sprouted up in many parts
of Uganda. They are loosely regulated, manned by primary
healthworkers and do not require a doctor’s prescription to
dispense treatment. Effective anti-microbial medication
such as Natamycin and Ciprofloxacin eye drops are not
available in such units. These could be potential stake-
holders to target in promotion of triage and referral
mechanisms for MK. We found that there was no referral
Figure 2. showing where patients first accessed treatment (n = 309).
Key: Clinic refers to clinic/pharmacy/drug shop, District is district hospital, MURHEC is the main eye hospital (Mbarara University and Referral
Hospital Eye Centre and Ruharo Eye Centre).
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mechanism for MK: all patients who came to the eye
hospital were self-referred.
Secondly, all the patients who visited a health facility we
given some treatment but none of the patients was ever
referred for specialist care. Most of the health centres
(II and III) are managed by mid-level cadres, who may
not have the necessary skills and tools to appreciate the
urgency and seriousness ofMK.General eye health training
has been previously reported to be limited amongmid-level
cadres in the region.26 In addition, Uganda is still grappling
with a major shortage of human resources for eye health.
An eye specialist is found at some level six facilities and
a mid-level ophthalmic cadre might be available in some
level IV onwards.27We plan to conduct a study into factors
around the health system that could be developed to
strengthen treatment, triage and referral.
Figure 3. The care seeking journey of patients with microbial keratitis and the time taken at each step (n = 276).
In this analysis, only patients with complete data were included. START refers to when the symptoms started. Facility refers to a health
centre or clinic/pharmacy and not necessarily the hierarchy of the health centres.
Table 4. Money spent by patients per number of facilities visited before coming to the eye hospital.
Cost of care median (IQR) in Uganda Shillings*
Facility n (%) Transportation Consultation Medicine Total expenditure
0 58 (18.5%) 11,000 (4,000–20,000) 15,000 (0–15,000) 0 (0–27,000) 30,000 (7,000–63,000)
1 147 (52%) 19,500 (10,000–33,000) 15,000 (15,000–15,000) 19,800 (2,750–99,500) 52,000 (31,000–142,000)
2 58 (18.5%) 22,000 (15,000–37,000) 15,000 (0–15,000) 25,750 (6,000–80,000) 67,750 (34,250–142,500)
3 29 (9%) 30,000 (19,000–51,000) 15,000 (0-15,000) 28,500 (3,000–70,000) 78,250 (32,000–209,000)
4 6 (2%) 62,500 (33,000–143,000) 12,500 (10,000–30,000) 170,500 (78,000–343,500) 284,000 (118,000–439,500)
p value of test for trend <0.0001
*All money is quoted in Uganda shillings. The US $ exchange rate was US $1: Uganda shillings 3,700 (2017). Ɨ0-direct presenters who did not visit any other
facility before coming to the eye hospital. Patients with incomplete data were not included in this analysis
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Thirdly, we found in our study that most patients used
TEM after having been to a health facility (secondary use).
This is worrying because these were patients who could
have been sensitised against TEM use at the health facil-
ities where they first presented. This was a missed oppor-
tunity that needs to be addressed.
Fifty-eight (19%) of the patients were direct presen-
ters. As expected, people who had large households,
those who lived far from the eye hospital and those
who used TEM were less likely to present directly to
the eye hospital. Understandably, use of TEM and
having a large household were negative predictors for
being a direct presenter. Most of the people who used
TEM used it at home and this was marked as
a treatment event in our study design. Many patients
in our cohort were heads of households and the sole
bread winners, they might have preferred to first seek
treatment at a place near home.
The cost of care was variable depending on the num-
ber of facilities visited. Most of the money was spent on
drugs, and transportation. The public health system in
Uganda is largely free or highly subsided. Expenses are
incurred on transportation and sometimes medicines
when they are out of stock. For the case of MK, drugs
such as Natamycin have only been erratically and expen-
sively supplied by select private pharmacies and not
available in the public health system. We anticipate this
to change as Natamycin was recently added on the
WHO essential medicines list.28
Strengths/limitations
This study was the first in SSA to systematically collect
information on howMK patients seek care and what influ-
ences their pattern. It provides useful information on key
health system gaps that need strengthening. Before this
study, it had been thought that patients had poor health
seeking behaviour, however, what we found was that
majority of people presented to a health facility quite early
after the onset of symptoms. Secondly, although TEM use
was a known problem, this study showed that the bigger
problem was secondary TEM use, that is patients who
opted to use TEM even after they had been to a health
facility.
Although we collected information on distance cov-
ered and treatment given at each level, it was difficult
to analyse for these because most patients did not come
to the eye hospital with their medicine and could not
recall the names. There were many circular move-
ments that made it complicated to analyse total dis-
tance covered by each patient. A qualitative approach
in discussing with patients what informed their choice
of self-referral or direct presentation would have
strengthened the evidence in this study.
Conclusion
Delayed presentation to a specialist eye hospital is
a problem in the care of MK, and that this appears to be
largely attributable to slow referral through the health
system. There are opportunities for health education,
early referral, appropriate treatment and sensitization
against TEM use that could be utilized to improve care of
MK.More needs to be done to understand what goes on in
the health system and how this can be strengthened.
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Table 5. Univariable and multivariable ordinal logistic regression analysis of factors associated with delay among patients with
microbial keratitis (n = 309).
Variable
Univariable analysis Multivariable analysis
cOR (95% CI) p value aOR (95% CI) p value
Age in years 1.009 (0.994–1.019) 0.140
Sex (being male) 1.06 (0.71–1.58) 0.792
Marital status (being married) 0.86 (0.55–1.33) 0.316
Occupation (being a farmer) 1.24 (0.80–1.93) 0.339
Being head of household 0.83 (0.54–1.27) 0.394
Number of people in household (increase/one person) 1.14 (0.85–1.51) 0.365
Distance to the eye hospital (every 10km increase) 1.036 (1.003–1.) 0.034
Distance from nearest health centre (increase per 1km) 1.01 (0.97–1.06) 0.501
Positive history of trauma 0.96 (0.62–1.49) 0.860
Positive history of TEM Use 1.73 (1.14–2.62) 0.010 1.58 (1.03–2.43) 0.038
Other facilities visited before eye hospital
Nil (direct presenters) 1 0.0002 1 0.001
One facility 2.95 (1.63–5.38) 2.74 (1.53–4.92)
Two facilities 3.62 (1.74–7.52) 2.58 (1.30–5.15)
Three facilities 4.12 (1.82–9.34) 3.26 (1.42–7.45)
Four facilities* 15.5 (2.65–90) 14.3 (2.45–83.7)
*two patients had visited five facilities and one patient six facilities, these were dropped from the analysis
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